Abstracts
If you reside in an 可循环的country ,you will receive a promo code via email on the date the submission site opens in late April.If you have not received a code and live in an eligible country,please contact meetings@ashg.org 。
Submission Guidelines and Policies
The submitting author must be the first(presenting)author。 Abstracts must be the original work of the submitting author。 An individual may be first(presenting)author of only one,one abstract。 There is no limit to the number of times an individual may appear as co-author on abstracts。 Co-authors do not receive communication related to the abstract。 First(presenting)authors are responsible for coordinating communication with co-authors。 The first(presenting)author must present the gene symbol and/or name the identified marker at the meeting if you are reporting the mapping,linkage,or association of a locus to a phenotype。 (presenting)author becomes necessary,you must inform ASHG by emailing meetings@ashg.org upon confirmation of your abstract acceptance。 Substitution is not allowed without prior written approval。 Authors who fail to notify ASHG thatthey cannot attend may not be invited to present at future meetings。 Duplicate abstracts are not permitted regardless of changes in authorship order。 Abstracts suspected to be duplicates may be rejected during the review process。 Please note that due to U.S.OFCC comprehensive sanctions ,可供选择的资源有限Travel Awards或ASHG Trainee Research Excellence Awards:Iran; Cuba; Russia; Syria; Dem。 People’s Rep of Korea(North Korea); and the Crimea,Donetsk,and Luhansk regions of Ukraine。
途径,途径 are used to categorize the focus of the session。 Submitters must choose one of the following tracks that best fits their abstract:Basic or Translational Research; Clinical Research; Diversity,Equity,and Inclusion; Ethical,Legal,and Social Issues; Teaching or Education; or Other。 Topics allow the Program Committee to accurately review abstract submissions。 Submitters must choose one main topic that best fits their abstract from the provided 车站,车站 。 Keywords aid in the review process and determine placement of the abstract in a session。 Submitters must choose at least one,but no more than five,keywords from the provided 照明、灯具 。 选择,选择 primary audience is used to assist tagging programmed abstracts for attendees to find suitable sessions to attend。 Submitters must choose one of the following primary audiences for their abstract:Clinicians; Educators; Genetic Counselors; Researchers; 列车; Other。
It is the authors’responsibility to update the submission concerning any acceptances that occur before the submission deadline of June5。 For abstracts that are previously published,authors are strongly encouraged to describe any advancement beyond published work that will be presented。 At time of assigning platform talks,the Program Committee will independently verify whether there is a publication available with an acceptance date before June5 Failure to disclose prior publication will result in abstracts being deprioritized for oral presentation in plenary or platform sessions。
可接受的peer-reviewed publication,or Accepted for oral presentation at other conferences。
ASHG endorses the protections embodied in the principles of the 辅助装置,辅助装置 and the,并且 Belmont Report ,and their expansion in the regulations governing research supported by the U.S.Government( 45 CFR Part46 )。 ASHG does not endorse and will not publish the results of research that was not conducted in accordance with these principles。 Investigations involving animals reported in abstracts must have been conducted in conformance with approved principles of the care and use of animals in research。
Iam submitting this abstract with the intent of attending and presenting mywork in person at the American Society of Human Genetics Annual Meeting being held November5-92024,in Denver,CO.I understand that itif Ido not pay for registration and attend in person,my abstract may withdrawn and opy in,CO, forfeited。 Iunderstand that ASHG is not making any commitments to host virtual or hybrid content formats and reserves the right,at its sole discretion,to make adjustments to presentation format and style。 I understand that in submitting an abstract,I am authorizing ASHG to contact me about its Annual Meeting,including the status of my abstract。 Iwill submit only one abstract as first author。 Iunderstand that I may only serve as presenting author forone accepted presentation,including Featured Symposia。 Iunderstand that as first author,I must notify all authors of any and all correspondence relating to this abstract submission。 I confirm that each co-author has been informed of this abstract submission and has agreed to all information as it was submitted。 I verify that any reported human participants research was conducted with participants’voluntary,informed consent,with approval by an appropriate research ethics committee,and consistent with the principles of research ethics,such as those described in the 辅助装置,辅助装置 ,and 正常报告 。 预置Author Disclosure:Ifmy abstract is accepted asa platform or plenary(oral)presentation,Iunderstand that I must include a conflict-of-interest slide as part of my presentation and that I must provide verbal and written disclosures to attendees。 Presenting Author Disclosure:Ifmy abstract is accepted as a platform or plenary(oral)presentation,I agree to use generic names(i.e.,non-branded names)inmy presentation as much as possible。 Specific products of ineligible companies will neither be promoted nor disparaged。 The content of my presentation will not contain advertisements for aspecific product,company,and/or service nor contain any logos of an 可供选择的company .In addition,I agree to disclose on the required disclosure slide any unlabeled/unapproved uses of drugs or products referenced in my presentation。
分布式、reproduce、license、display、perform、lend、lease、or transfer rights to the Collective Works to third parties, 预应力工作,and Register the Collective Works in ASHGs own name with the U.S.Copyright Office。
Abstract title and author names: Can be released at any time。 Abstract text: Can only be released after the meeting program(with the abstract text)is made public。 Linking to the abstract text on the ASHG website is suggested。 Findings outlined in the abstract (whether a poster or oral presentation):Canonly be released after the presentation has occurred。
Abstract Review and Notification
Topic categories must be selected by abstract submitters but may be reassigned during review by the PC to ensure appropriate expert review。 Each reviewer scores the abstracts independently,without knowledge of the name(s)and institution(s)of the submitter(s)or the scores given by the other reviewers。 In July,the PC meets to assign abstracts to plenary,platform,and poster sessions based on the cumulative score as well as the impact of the science and the balance of topics for ASHG’s multi-disciplinary audience。 The top-scoring abstracts are considered for inclusion in the plenary sessions。 Approximately300abstracts are selected for platform sessions。 The remaining accepted abstracts are assigned to posters,and the top-scoring poster abstracts are awarded the Reviewers’Choice designation。
The PC reserves the right to reject abstracts that lack scientific content or merit,lack human genetics research and/or data,or that merely announce the availability of a resource or service。 Abstract acceptance notifications will be sent to authors in early August。